May 6, 2020
SHORTEN YOUR DRUG DEVELOPMENT CYCLE BY IDENTIFYING AND CHARACTERIZING NEO-EPITOPE DIRECTLY FROM TISSUE USING MASS SPECTROMETRY
You might also be interested by
Press Releases
CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays
May 19, 2022
Proteomics/Mass Spectrometry
More infoBrochures
High Performance Technologies for Cytokine Measurement
November 8, 2021
Immune Monitoring
More info